These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 14551027)
1. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment. Stell D; Marshall H; Bradley JA; Bolton EM Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027 [TBL] [Abstract][Full Text] [Related]
2. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Hirahara H; Tsuchida M; Watanabe T; Haga M; Matsumoto Y; Abo T; Eguchi S Transplantation; 1995 Jan; 59(1):85-90. PubMed ID: 7839434 [TBL] [Abstract][Full Text] [Related]
3. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production. Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance. Krieger NR; Most D; Bromberg JS; Holm B; Huie P; Sibley RK; Dafoe DC; Alfrey EJ Transplantation; 1996 Nov; 62(9):1285-92. PubMed ID: 8932273 [TBL] [Abstract][Full Text] [Related]
5. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion. Rehman A; Tu Y; Arima T; Linsley PS; Flye MW Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584 [TBL] [Abstract][Full Text] [Related]
6. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulation. Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Westermann J Clin Exp Immunol; 1997 Oct; 110(1):63-71. PubMed ID: 9353150 [TBL] [Abstract][Full Text] [Related]
8. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation. Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096 [TBL] [Abstract][Full Text] [Related]
10. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations. Qi Z; Riesbeck K; Ostraat O; Tufveson G; Ekberg H Transpl Immunol; 1997 Sep; 5(3):204-11. PubMed ID: 9402687 [TBL] [Abstract][Full Text] [Related]
11. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects. Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031 [TBL] [Abstract][Full Text] [Related]
13. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway. Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567 [TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Jung S; Toyka K; Hartung HP Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758 [TBL] [Abstract][Full Text] [Related]
16. Effects of the anti-CD2 mAb OX34 on in vivo proliferation. Hoffmann JC; Herklotz C; Zeitz M; Bayer B; Zeidler H; Westermann J Ann N Y Acad Sci; 1998 Nov; 859():216-8. PubMed ID: 9928391 [TBL] [Abstract][Full Text] [Related]
17. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307 [TBL] [Abstract][Full Text] [Related]
19. Better-surviving liver grafts by the injection of anti-CD2 antibody: the important roles of host CD8+ and CD2+CD28+ T cells in chronic graft rejection and beta type platelet-derived growth factor receptor (PDGFR-beta) expression on apoptotic liver grafts. Nakatsuji T Tohoku J Exp Med; 1999 Mar; 187(3):215-25. PubMed ID: 10458478 [TBL] [Abstract][Full Text] [Related]
20. Studies on the participation of different T cell subsets in rat liver allograft rejection. Comparison of liver with heart graft. Sumimoto R; Kimura H; Yamaguchi A; Kamada N Transpl Int; 1992; 5 Suppl 1():S636-8. PubMed ID: 14621896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]